ApoA-1 versus HDL-C as markers of cardiovascular risk

Selin Bilgic1, Karol Pencina2, Michael Pencina3

  • 1Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, 1001 Decarie Blvd, Montreal, Quebec H4A 3J1, Canada (Bilgic, K. Pencina, M. Pencina, Dufresne, Thanassoulis, and Sniderman).

PubMed

Insights

Apolipoprotein A-1 (apoA-1) and high-density lipoprotein cholesterol (HDL-C) show similar associations with atherosclerotic cardiovascular disease (ASCVD) risk. Upon analysis, apoA-1 explained more of the risk than triglycerides, suggesting HDL-C

Area of Science:

  • Cardiovascular Research
  • Biomarker Analysis
  • Lipid Metabolism

Background:

  • Conflicting data exists on the relative importance of apolipoprotein A-1 (apoA-1) versus high-density lipoprotein cholesterol (HDL-C) in predicting atherosclerotic cardiovascular disease (ASCVD) risk.
  • Understanding the precise role of these markers is crucial for accurate risk assessment.

Purpose of the Study:

  • To directly compare the predictive capabilities of apoA-1 and HDL-C for cardiovascular risk.
  • To investigate the interaction between apoA-1 and HDL-C in ASCVD risk prediction.

Main Methods:

  • Utilized residual discordance analysis with Cox proportional hazard models.
  • Analyzed data from 291,995 UK Biobank participants with a median follow-up of 11 years.
  • Performed interaction tests and decomposed HDL-C into apoA-1, log-triglyceride, and residual components.

Main Results:

  • Both apoA-1 and HDL-C demonstrated similar associations with ASCVD risk (HR=0.85 for both).
  • Significant interaction was observed between apoA-1 and HDL-C, modifying their individual effects.
  • Upon decomposition, apoA-1 accounted for the largest portion of HDL-C's effect, more so than log-triglycerides.

Conclusions:

  • HDL-C and apoA-1 exhibit equivalent strength in association with ASCVD risk, with their effects being mutually modifying.
  • Decomposition analysis indicates apoA-1 is a stronger determinant of HDL-C's risk-predictive capacity compared to triglycerides.
  • These observational findings suggest that triglyceride levels may not solely determine the relationship between HDL and cardiovascular risk.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
688
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
562
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
798
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
745